Autologously Humanized Mice for Immune-Oncologic Studies

Curr Protoc Pharmacol. 2020 Jun;89(1):e76. doi: 10.1002/cpph.76.

Abstract

With the rapid approval of immune checkpoint inhibitors for lung, melanoma, breast, genitourinary, and hematological malignancies, the hematopoietic cells in the tumor microenvironment (TME) are now considered an important, if not essential, consideration for cancer scientists. In many instances, syngeneic murine models have not been highly predictive for responsiveness in clinical trials. Our limited understanding of the human TME have, therefore, precluded a rational translation of immunotherapeutic combinations. This has led to the adoption of hematopoietic humanized murine models for the study of human tumor immunology in vivo. However, concerns about chimerism rates, HLA mismatching, and incomplete reconstitution of the innate immune system have driven a quest for improvements in these allogeneic humanized murine systems. Presented in this article is a completely autologous xenotransplantation method for reconstituting the human tumor immune microenvironment in vivo without the use of a patient's peripheral blood which is known to be associated with low engraftment rates. With this new approach, the current limitations of allogeneic humanized models are avoided by using matched bone marrow cells (BMCs) and derived tumor xenoplants (PDXs) from solid tumors in cancer patients. This autologous system provides a platform for studying endogenous lymphocytic and myeloid cell infiltration into the human tumor in vivo. © 2020 Wiley Periodicals LLC. Basic Protocol: Autologous reconstitution of human tumors Support Protocol 1: Transduction of BMCs and/or tumor cells prior to autologous reconstitution Support Protocol 2: Modeling immunotherapeutic agents in an autologously humanized model.

Keywords: autologous reconstitution; head neck carcinoma; humanized mice; tumor microenvironment.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Bone Marrow Cells / immunology
  • Bone Marrow Transplantation / methods
  • Cells, Cultured
  • Disease Models, Animal
  • Female
  • Hematopoietic Stem Cells / immunology
  • Heterografts / immunology
  • Humans
  • Immune Checkpoint Inhibitors / immunology
  • Male
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Myeloid Cells / immunology
  • Neoplasms / immunology*
  • Tumor Microenvironment / immunology
  • Xenograft Model Antitumor Assays / methods

Substances

  • Immune Checkpoint Inhibitors